AnPac Bio-Medical Science
| General Information | |
| Business: |
We are a biotechnology company focusing on early cancer screening and detection. We market and sell a multi-cancer screening and detection test that uses our innovative, patented CDA technology and our proprietary CDA device. In addition to early cancer screening and detection, our CDA technology has demonstrated potential to assist physicians in cancer diagnosis, prognosis and recurrence. |
| Industry: | MEDICAL LABORATORIES |
| Employees: | 101 |
| Founded: | 2010 |
| Contact Information | |
| Address | 801 Bixing Street, Bihu County Lishui, Zhejiang Province 323006, People’s Republic of China |
| Phone Number | +86-578-2051-6666 |
| Web Address | https://www.anpacbio.com/ |
| View Prospectus: | AnPac Bio-Medical Science |
| Financial Information | |
| Market Cap | $134.4mil |
| Revenues | $1.6 mil (last 12 months) |
| Net Income | $-11.3 mil (last 12 months) |
| IPO Profile | |
| Symbol | ANPC |
| Exchange | NASDAQ |
| Shares (millions): | 1.3 |
| Price range | $12.00 - $12.00 |
| Est. $ Volume | $16.0 mil |
| Manager / Joint Managers | WestPark Capital/ Univest Securities |
| CO-Managers | - |
| Expected To Trade: | 1/30/2020 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |